Share: Facebook Twitter LinkedIn
Activity Provided By:

ACHL

Multidisciplinary Viewpoints on NTM-LD Diagnosis and Management

Access Activity

Overview / Abstract:

In two virtual roundtables, a pulmonologist, infectious disease specialist, and clinical pharmacist share their experiences in addressing challenges in diagnosing and treating patients with NTM-LD. The expert panel discusses strategies for expediting diagnosis and improving patient care and outcomes within the context of a patient’s reflections on the path to diagnosis and their treatment experience. Through this approach, learners hear from a real-world patient as the multidisciplinary panel examines the timeline to diagnosis and approach to optimal management.

Expiration

Feb 28, 2023

Discipline(s)

Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME

Format

Online, Webinar / Webcast / Video

Credits / Hours

1.50 AMA PRA Category 1 Credit(s). 1.50 Contact Hours

Accreditation

ACCME, ACPE

Presenters / Authors / Faculty

Christina O’Connor, PharmD, BCPS, AAHIV-P
Antimicrobial Stewardship Clinical Pharmacist Manager
Assistant Professor of Pharmacy, Mayo Clinic College of Medicine and Science
Rochester, MN

Stephen Ruoss, MD
Professor of Medicine, Pulmonary, Allergy and Critical Care Medicine
Stanford University School of Medicine
Stanford, CA

Jason Stout, MD, MHS
Professor of Medicine, Division of Infectious Diseases, Department of Medicine
Duke University
Chapel Hill, NC

Activity Specialities / Related Topics

Family Medicine, Infectious Disease, Internal Medicine, Pharmacology, Primary Care, Pulmonary Medicine / COPD

Sponsors / Supporters / Grant Providers

Supported by an educational grant from Insmed Incorporated.

Keywords / Search Terms

ACHL Ruoss, Stout, Multidisciplinary, roundtable, diagnosis, epidemiology, pathogenicity, azithromycin, rifampicin, ethambutol, amikacin, streptomycin, isoniazid, imipenem, cefoxitin, tigecycline, clofazimine, linezolid, moxifloxacin NTM-LD, nontuberculous, mycobacterial, lung disease; rifabutin, clarithromycin, Mycobacterium avium complex, MAC Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map